Madrigal Pharmaceuticals, Inc. (MDGL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.06B |
| Enterprise Value | 13.22B |
| P/E Ratio | -47.45 |
| PEG Ratio | -1.62 |
| Price/Sales Ratio | 10.3 |
| Price/Book Ratio | 27.02 |
| Enterprise/Revenue | 10.4 |
| Enterprise/EBITDA | -41.89 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.27 |
| Operating Margin | -0.28 |
AD
Management Effectiveness
| Return On Assets | -0.25 |
| Return On Equity | -0.5 |
Income Statement
| Revenue | 958.4M |
| Revenue/Share | 39.01 |
| Gross Profit | 902.26M |
| EBITDA | -264.47M |
| Net Income | -288.28M |
| Diluted EPS | -12.85 |
Balance Sheet
| Total Cash | 817.93M |
| Total Cash/Share | 28.17 |
| Total Debt | 347.31M |
| Total Debt/Equity | 0.64 |
| Current Ratio | 3.5 |
| Book Value Per Share | 18.72 |
Price History
| 52-Week Change | 78.89 |
| 52-Week High | 615 |
| 52-Week Low | 276.67 |
| Moving Average 50 Days | 510.07 |
| Moving Average 200 Days | 493.04 |
Statistics
| Average Volume | 312,598 |
| Shares Outstanding | 23.06M |
| % Held by Institutions | 105.97 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | July 25, 2016 |
AD
